Picture EBD Group BioPharm America 2021 Digital BPA2021 650x80
Organisation › Details

Celleron Therapeutics Ltd.

Celleron is an oncology company focussed on the clinical development of new and innovative therapies to treat cancer. Celleron is developing a novel group of clinical products, supported by predictive companion diagnostics, that act through defined molecular mechanisms to prevent cancer cell growth. The company's lead products are in clinical trials, supported by a biomarker platform that allows responsive patients to be identified. The company has deep relationships with Oxford University and is located on the Oxford Science Park, United Kingdom. *


Period Start 2020-11-19 existent
Products Industry cancer drug
  Industry 2 drug development
Person Person Fleming, Bill (Oxitec 201704 CFO joined 2010 before Bayer + OBN 201704– Board Member)
Region Region Oxford, Oxfordshire
  Country United Kingdom (GB)
  City n. a. Oxford, Oxfordshire
    Address record changed: 2020-12-02
Basic data Employees n. a.
    * Document for �About Section�: SynOx Therapeutics Ltd.. (11/19/20). "Press Release: SynOx Therapeutics Raises €37M in Series A Financing. HealthCap and Medicxi Co-lead, Joined by Forbion and Gimv". Dublin.
Record changed: 2021-08-23


Picture EBD Group Connector Personal Networking in Life Sciences 650x80

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]


Picture Demy-Colton BioFuture 2021 NYC E Hand 650x300px

» top